Isothermal Nucleic Acid Amplification Technology Market Likely To Reach A Valuation Of Around USD 4.3 Billion By 2025:Key Participant Eiken Chemical Co. Ltd., Hologic, Inc.

San Francisco, 03 January ,  Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis By Product, By Technology (NASBA, HDA, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2), And Segment Forecasts, 2018 – 2025

The global isothermalnucleic acid amplification technology (INAAT) market is expected to reach USD 4.3 billion by 2025, growing at a CAGR of 11.8%, according to a new report by Grand View Research, Inc. This can be attributed to significant rise in awareness regarding need for rapid and on-time testing for chronic and infectious diseases. Global increase in adoption of INAAT for detection of HIV, hepatitis A & B, and sexually transmitted diseases is considered to be a high impact rendering driver for growth.

Loop-Mediated Isothermal Amplification is one of the most preferred nucleic acid amplification methods because of its ability to provide point of care testing, thus leading to increased adoption. The recently-introduced Nicking Enzyme Amplification Reaction (NEAR) and Helicase-dependent amplification (HDA) technologies are expected to experience exponential growth during the forecast period owing to their patent protection.

In addition, owing to recent epidemics of infectious diseases, such as tuberculosis, Zika virus, and influenza, importance of point of care diagnosis has increased especially in developing countries. This is also anticipated to boost demand for this technology in these regions.

Access Full Research Report On Isothermal Nucleic Acid Amplification Technology (INAAT) Market  Analysis:
www.grandviewresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-inaat-market

Further Key Findings From the Report Suggest:

·         Reagents are expected to be fastest growing products owing to their high usage in all INAAT procedures

·         TMA was identified as the largest technology segment by revenue share in 2016 owing to its high adoption

·         Infectious disease diagnostics is expected to be the fastest growing application owing to development of numerous assays for detection of specific infectious diseases

·         Hospitals dominated the end user segment in 2016 with the largest share and are expected to be continue dominance over the forecast period owing to the high usage of INAAT in hospitals globally

·         North America held the largest share of the global market in 2016, and the U.S. held the largest revenue share in the region owing to rise in infectious diseases, availability of government funds, prevalence of cancer, application of MDx in cancer screening & genetic disorders, and self-monitoring techniques

·         The molecular diagnostics industry in Asia Pacific is projected to witness substantial growth over the next decade due to various developments in major economies, especially in the NASBA, NEAR, and HDA technology segments

·         Some of the key players in the INAAT market include Alere; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; ThermoFisher Scientific; and Becton, Dickinson & Company

·         Major players have been engaging in numerous strategic initiatives such as mergers and acquisitions to increase global presence and improve market share.

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global INAAT market on the basis of product, technology, application, end-use, and region:

Isothermal Nucleic Acid Amplification By Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Instrument

·         Reagent

Isothermal Nucleic Acid Amplification By Technology Outlook (Revenue, USD Million, 2014 - 2025)

·         NASBA

·         HDA

·         LAMP

·         SDA

·         SPIA

·         NEAR

·         TMA

·         RCA

·         RPA

·         SMAP2

·         Others

Isothermal Nucleic Acid Amplification By Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Blood screening

·         Infectious disease diagnostics

·         Cancer

·         Others

Isothermal Nucleic Acid Amplification By End Use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals,

·         Central and reference labs

·         Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    China

o    India

o    Japan

·         Central & South America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa

Access Full Press Release of this Report:

www.grandviewresearch.com/press-release/global-isothermal-nucleic-acid-amplification-technology-inaat-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Women’s Health Diagnostics Market Expected To Trigger A Revenue Increase To USD 76.2 Billion By 2025:Key Participant Siemens Healthcare Private Limited, Hologic, Inc.

San Francisco, 17 December 2018,  Women’s Health Diagnostics Market Size, Share & Trends Analysis Report By End Use, By Application (Cancer, Infectious Disease, Osteoporosis, Pregnancy, Prenatal), and Segment Forecasts, 2018 - 2025

The global women’s health diagnostics market size is expected to reach USD 76.2 billion by 2025, according to a new report by Grand View Research, Inc. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women’s health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Access Full Research Report On Women’s Health Diagnostics Market Analysis:
www.grandviewresearch.com/industry-analysis/womens-health-diagnostics-market

Further key findings from the report suggest:

·         Increasing investments by governments and private bodies and rising disposable income are providing a push to the market

·         Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer

·         Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests

·         Geographically, North America was the leading revenue contributor to the women’s health diagnostics market in 2017. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

·         Some of the key players are Siemens Healthcare Private Limited; Hologic, Inc.;GE Healthcare; F. Hoffmann-La Roche Ltd.; bioMérieux SA; Koninklijke Philips N.V; Abbott; Becton, Dickinson and Company, Quest Diagnostics, Inc.; and PerkinElmer, Inc.

Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global women’s health diagnostics market based on application, end use, and region:

Women’s Health Diagnostics Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Cancer

o    Breast Cancer Testing

o    Cervical Cancer Testing

o    Ovarian Cancer Testing

·         Infectious Disease Testing

·         Osteoporosis Testing

·         Pregnancy and Fertility Testing

·         Prenatal Testing

Women’s Health Diagnostics End Use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospital and Diagnostics Centers

·         Home

Women’s Health Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    U.K.

o    Germany

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

o    Mexico

·         Middle East & Africa

o    South Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-womens-health-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Structural Health Monitoring Market Expected To Trigger A Revenue Increase To USD 4.34 Billion By 2025

San Francisco, 17 December 2018,  Structural Health Monitoring (SHM) Market By Solution, By Application (Bridges & Dams, Buildings & Stadiums, Vessels & Platforms), By Technology (Wired, Wireless), And Segment Forecasts, 2018 - 2025

The global structural health monitoring market size is estimated to reach USD 4.34 billion by 2025, according to a study conducted by Grand View Research, Inc., rising at a CAGR of 17.3% during the forecast period. Growing investments in infrastructural development and government regulations mandating implementation of sensors and data acquisition systems to monitor structure health are expected to augment the market. Increasing age of existing bridges and dams and rising focus on infrastructural advancements including construction of new bridges, dams, buildings, and stadiums are also providing a push to the market.

Superior infrastructure is essential for regional development and it helps to increase productivity of the private as well as public sectors. Therefore, rapid infrastructural development across the globe is one of the primary growth stimulants for the market. These systems help in reducing cost by removing need for inspection staff and maintenance. Additionally, with ongoing advancements in technology, these systems are being used in applications such as diagnosing vessels and platforms in marine industries, aircraft frames in aerospace and defense, and inspection of large machines.

North America is projected to dominate the market throughout the forecast horizon owing to surging demand from applications such as bridges & dams and buildings & stadiums. However, Asia Pacific is poised to post the highest CAGR of 18.9% during the same period. This is owing to increasing investments in the civil infrastructure sector, along with industries such as aerospace, defense, marine, and manufacturing. Moreover, in 2014, the Chinese government laid down new regulations mandating use of SHM systems while building new architectural structures and bridges. They have restricted replacement time period for an embedded sensor to 20 years and three to five years for a sensor placed on the surface of the bridge. Furthermore, expanding production of oil sands and shale gas in regions such as Africa and Asia are anticipated to stir up the demand for structural health monitoring systems.

Access Full Research Report On  Structural Health Monitoring Market  Analysis:

www.grandviewresearch.com/industry-analysis/structural-health-monitoring-shm-market

Further key findings from the study suggest:

·         The hardware segment is likely to dominate the structural health monitoring market throughout the forecast period owing to higher cost of sensors and data acquisition systems as compared to that of software and services

·         In terms of application, the market for structural health monitoring is dominated by bridges & dams and the trend is estimated to continue until 2025. This is due to increasing investments in order to check for health of structures, thus ensuring public safety

·         Prominent industry participants include National Instruments Corporation; Structural Monitoring Systems; Digitexx Data Systems, Inc.; and Pure Technologies.

Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/communications-infrastructure-systems-and-software

Grand View Research has segmented the global structural health monitoring market based on solution, application, technology, and region:

Structural Health Monitoring Solution Type (Revenue, USD Million, 2015 - 2025)

·         Hardware

o    Sensors

o    Data Acquisition Systems

o    Others

·         Software & Services

Structural Health Monitoring Application Type (Revenue, USD Million, 2015 - 2025)

·         Bridges & Dams

·         Building & Stadiums

·         Vessels & Platforms

·         Airframes & Wind Turbines

·         Large Machines & Equipment

Structural Health Monitoring Technology Type (Revenue, USD Million, 2015 - 2025)

·         Wired

·         Wireless

Structural Health Monitoring Regional Outlook (Revenue, USD Million, 2015 - 2025)

·         North America

o    U.S.

o    Canada

o    Mexico

·         Europe

o    U.K.

o    Germany

·         Asia Pacific

o    China

o    Japan

o    India

·         South America

o    Brazil

·         Middle East & Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-structural-health-monitoring-shm-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/